Related references
Note: Only part of the references are listed.Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNI
Jon B. Toledo et al.
ACTA NEUROPATHOLOGICA (2013)
Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association
Keith A. Johnson et al.
ALZHEIMERS & DEMENTIA (2013)
Synapse-Binding Subpopulations of Aβ Oligomers Sensitive to Peptide Assembly Blockers and scFv Antibodies
Pauline T. Velasco et al.
ACS CHEMICAL NEUROSCIENCE (2012)
Measurement of Aß1-42 in cerebrospinal fluid is influenced by matrix effects
J. Randall Slemmon et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Molecular MRI enables early and sensitive detection of brain metastases
Sebastien Serres et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Hybrid magnetic nanostructures (MNS) for magnetic resonance imaging applications
Mrinmoy De et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
Transgenic Mice as a Model of Pre-Clinical Alzheimers Disease
M. T. Ferretti et al.
Current Alzheimer Research (2011)
Extracellular and intraneuronal HMW-AbetaOs represent a molecular basis of memory loss in Alzheimer's disease model mouse
Ayumi Takamura et al.
MOLECULAR NEURODEGENERATION (2011)
Stabilization and functionalization of iron oxide nanoparticles for biomedical applications
Esther Amstad et al.
NANOSCALE (2011)
AMYLOID Little proteins, big clues
Jim Schnabel
NATURE (2011)
The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease
Sergio T. Ferreira et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2011)
Fine Tuning of the Relaxometry of γ-Fe2O3@SiO2 Nanoparticles by Tweaking the Silica Coating Thickness
Sonia L. C. Pinho et al.
ACS NANO (2010)
Amyloid-beta Oligomers: Possible Roles as Key Neurotoxins in Alzheimer's Disease
Alex L. Lublin et al.
MOUNT SINAI JOURNAL OF MEDICINE (2010)
Coating Optimization of Superparamagnetic Iron Oxide Nanoparticles for High T2 Relaxivity
Sheng Tong et al.
NANO LETTERS (2010)
Bilayers as Phase Transfer Agents for Nanocrystals Prepared in Nonpolar Solvents
Arjun Prakash et al.
ACS NANO (2009)
Inorganic Nanoparticles for MRI Contrast Agents
Hyon Bin Na et al.
ADVANCED MATERIALS (2009)
Targeting Generation of Antibodies Specific to Conformational Epitopes of Amyloid beta-Derived Neurotoxins
Mary P. Lambert et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2009)
Nanoscale assembly of amine-functionalized colloidal iron oxide
K. C. Barick et al.
JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS (2009)
A Novel Type of Dual-Modality Molecular Probe for MR and Nuclear Imaging of Tumor: Preparation, Characterization and in Vivo Application
Shujie Liu et al.
MOLECULAR PHARMACEUTICS (2009)
Ultrastable Iron Oxide Nanoparticle Colloidal Suspensions Using Dispersants with Catechol-Derived Anchor Groups
Esther Amstad et al.
NANO LETTERS (2009)
Targeting activated microglia in Alzheimer's pathology by intraventricular delivery of a phagocytosable MRI contrast agent in APP23 transgenic mice
Adrian P. Mundt et al.
NEUROIMAGE (2009)
Monoclonal antibodies that target pathological assemblies of A beta
Mary P. Lambert et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Intraneuronal β-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations:: Potential factors in amyloid plaque formation
Holly Oakley et al.
JOURNAL OF NEUROSCIENCE (2006)
A specific amyloid-β protein assembly in the brain impairs memory
S Lesné et al.
NATURE (2006)
Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1
M Ohno et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease
DG Georganopoulou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
WE Klunk et al.
ANNALS OF NEUROLOGY (2004)
Ultra-large-scale syntheses of monodisperse nanocrystals
J Park et al.
NATURE MATERIALS (2004)
Synaptic targeting by Alzheimer's-related amyloid β oligomers
PN Lacor et al.
JOURNAL OF NEUROSCIENCE (2004)
Alzheimer's disease-affected brain:: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss
YS Gong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
R Kayed et al.
SCIENCE (2003)
Femtomole immunodetection of synthetic and endogenous amyloid-beta oligomers and its application to Alzheimer's disease drug candidate screening
L Chang et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2003)
Targeting small Aβ oligomers:: the solution to an Alzheimer's disease conundrum?
WL Klein et al.
TRENDS IN NEUROSCIENCES (2001)
Share Paper
